Passive-active immunoprophylaxis for all infants born from HBeAG-negative chronic HBV-infected mothers: Is it a cost-effective strategy?
Elefsiniotis
Ioannis S
IS
Department of Internal Medicine, Alexandra Hospital, University of Athens, Greece.
Papadakis
Miltiadis A
MA
Vlahos
George
G
Antsaklis
Aris
A